Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
Wang D, Fu B, Peng Z, Yang D, Han M, Li M, Yang Y, Yang T, Sun L, Li W, Shi W, Yao X, Ma Y, Xu F, Wang X, Chen J, Xia D, Sun Y, Dong L, Wang J, Zhu X, Zhang M, Zhou Y, Pan A, Hu X, Mei X, Wei H, Xu X.
Wang D, et al. Among authors: li w, li m.
Front Med. 2021 Jun;15(3):486-494. doi: 10.1007/s11684-020-0824-3. Epub 2021 Mar 9.
Front Med. 2021.
PMID: 33687643
Free PMC article.
Clinical Trial.